期刊文献+

丙二醇-肉豆蔻酸异丙酯系统中促透剂对来曲唑经皮透过性的影响 被引量:1

Effects of enhancers on the skin permeation of letrozole in the PG-IPM system
下载PDF
导出
摘要 目的考察在丙二醇(propylene glycol,PG)-肉豆蔻酸异丙酯(isopropyl myristate,IPM)系统(简称PI系统)中经皮促透剂对来曲唑经皮透过性的影响。方法采用水平双室扩散池,以离体大鼠皮肤作为透过屏障进行体外透过实验。结果在不含经皮促透剂时,来曲唑的累积透过量随体系中PG浓度的增加而增大。在PI系统[m(PG)∶m(IPM)=20∶100]中,N-甲基-2-吡咯烷酮、月桂氮卓酮、乳酸对来曲唑的透过具有显著的促进作用,司盘-80和二乙二醇单乙基醚具有轻微抑制作用,而油酸和吐温-80则有显著的抑制作用。结论在PI系统中经皮促透剂对来曲唑的经皮透过性具有不同的促透作用,为开发来曲唑的透皮给药贴剂提供参考数据。 Objective To assess the effect of penetration enhancers on the percutaneous permeability of letrozole in the propylene glycol and isopropyl myristate(PG-IPM,PI)system.Methods The modified Franz diffusion cells were adopted as the apparatus for skin permeation,excised rat abdominal skin as barrier.Results The accumulative permeation of letrozole increased with the increase of PG concentration in the systems containing no enhancers.In the PI[m(PG)∶m(IPM)=20∶100]system,NMP,azone and lactic acid showed significant enhancing effect while span-80 and TranscutolP moderately decreased letrozole penetration.Oleic acid and tween-80 had significant inhibition activity on letrozole permeability in this system.Conclusions The effect of different penetration enhancers on the percutaneous permeability of letrozole in the PI system is different.The results obtained from this study will be helpful in the development of transdermal patch of letrozole.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2010年第11期867-870,共4页 Journal of Shenyang Pharmaceutical University
基金 国家科技部重大新药创制项目(2008ZX09401-004)
关键词 来曲唑 丙二醇-肉豆蔻酸异丙酯系统 经皮促透剂 letrozole propylene glycol-isopropyl myristate system penetration enhancer
  • 相关文献

参考文献12

  • 1CHEN S, MASRI S, WANG X.in, et al. What do we know about the mechanisms of aromatase inhibitor resistance[ J ]. J Steroid Biochem Mol Biol, 2006,102 : 232 - 240.
  • 2MOM C H,BUIJS C,WILLEMSE P H,et al. Hot flushes in breast cancer patients[ J]. Crit Rev Oncol Hematol,2006 ,57 :63 - 77.
  • 3EDITH A P. The balance between risks and benefits: long-term use of aromatase inhibitors[ J]. Eur J Cancer,2006,4(Supp) : 16 - 25.
  • 4MIKI Y, SUZUKI T, SASANO H. Aromatase inhibitor and bone [ J ]. Biomed Pharmacother, 2007,61 : 540 - 542.
  • 5VANLANDEGHEM A A J, POORTMAN J,NABUURS M, et al. Endogenous concentration and subcellular distribution of estrogens in normal and malignant breast tissue [ J ]. Cancer Res, 1985,45 : 2900 - 2904.
  • 6LФbNNING P E, DOWSETF M, POWLES T J. Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer [ J ]. J Steroid Biochem, 1990, 35:355 - 366.
  • 7CHETRITE G S, CORTE P J, PHILIPPE J C, et al. Comparison of estrogen concentrations, estrone sulfa- tase and aromatase activities in normal, and in cancerous,human breast tissues[J]. J Steroid Biochem Mol Biol,2000,72:23 - 27.
  • 8GEISLER J, LФNNING P E. Endocrine effects of aromatase inhibitors and inactivators in vivo:review of data and method limitations [ J ]. J Steroid Biochem Mole Bioi,2005,95:75 - 81.
  • 9LABRIE F, LUU T V, LABRIE C, et al. Endocrine and intracrine sources of androgens in women:inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone [ J ]. Endocr Rev ,2003,24 : 152 - 182.
  • 10杨鹏,丁雪鹰,高静,高申.透皮促渗剂对盐酸氟西汀经皮渗透性的影响[J].第二军医大学学报,2007,28(11):1252-1254. 被引量:5

二级参考文献13

  • 1冀学芳,平其能,刘国杰,周轶.促进剂对马来酸噻吗洛尔经皮渗透的影响[J].中国药科大学学报,1996,27(1):6-9. 被引量:11
  • 2狄平平,徐远,张圩.盐酸氟西汀化学结构确证及其理化性质的研究[J].中国医药工业杂志,1996,27(7):317-319. 被引量:3
  • 3Harrison J E, Watkinson A C, Green D M, et al. The relative effect of azone and transcutol on permeant diffusivity and solubility in human stratum comeum[J]. Pharm Res, 1996, 13(4):542- 546.
  • 4Ito Y, Ogiso T, Iwaki M. Thermodynamic study on enhancement of percutaneous penetration of drugs by azonc [J]. Pharmacobiodyn, 1988, 11(11): 749-757.
  • 5Sugibayashi K, Nakayama S, Seki T, et al. Mechanism of skin penetration-enhancing effect by laurocapram [ J ]. J Pharm Sci, 1992, 81(1) :58-64.
  • 6Ogiso T, lwaki M, Bechako K, et al. Enhancement of percutaneous absorption by laumcapram[ J ]. J Pharm Sci, 1992, 81 ( 8 ) : 762 -767.
  • 7中国药典[S].一部,2005:229
  • 8De Klerk E. Patient compliance with enteric-coated weekly fluoxetine during continuation treatment of major depressive disorder[J]. J Clin Psychiatry, 2001,62:43-47.
  • 9Lundmark J, Reis M, Bengtsson F. Serum concentrations of fluoxetine in the clinical treatment setting [J]. Therapeut Drug Monitor, 2001,23: 139-147.
  • 10Howes D, Guy R, Hadgraft J. Methods for assessing pereutaneous absorption EJ~. Alternt Laborat Animals, 1996,24:81- 106.

共引文献13

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部